Also from this source

You just read:

Janssen Submits Supplemental New Drug Application to U.S. FDA for All-Oral, Once-Daily OLYSIO® (Simeprevir) in Combination with Sofosbuvir

News provided by

Janssen Therapeutics

Jul 23, 2015, 05:43 ET